why choose us

First received: July 25, 2024

Clinical Trial: Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV371 LAI in Healthy Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Malaria,Falciparum

Study Type: INTERVENTIONAL


Official Title: A First-in-Human, Single-Centre, Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of a Single Intramuscular Injection of MMV371 Long-Acting Injection Formulation in

Brief Summary: This three-cohort, first-in-human, healthy participant study aims to assess the test medicine's safety and tolerability, including injection site reactions and how it is taken up by the body when given as a single dose.For Cohort 1, up to 8 participants will be randomly assigned to receive the starting dose of the test medicine or dummy medicine (placebo) as a single intramuscular injection.For Cohort 2, if the safety and tolerability results from Cohort 1 are satisfactory, up to 8 participants will be…

Read more